0001891891-26-000002.txt : 20260624 0001891891-26-000002.hdr.sgml : 20260624 20260624165344 ACCESSION NUMBER: 0001891891-26-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260624 DATE AS OF CHANGE: 20260624 EFFECTIVENESS DATE: 20260624 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Quanta Therapeutics, Inc. CENTRAL INDEX KEY: 0001891891 ORGANIZATION NAME: EIN: 831445023 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-482575 FILM NUMBER: 261116618 BUSINESS ADDRESS: STREET 1: TWO TOWER PLACE, FLOOR 17 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 799-8230 MAIL ADDRESS: STREET 1: TWO TOWER PLACE, FLOOR 17 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D/A 1 primary_doc.xml X0708 D/A LIVE 0001891891 Quanta Therapeutics, Inc. TWO TOWER PLACE, FLOOR 17 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 (970) 742-4190 DELAWARE None None Corporation true Perry Nisen 2 Tower Place, Floor 17 San Francisco CA CALIFORNIA 94080 Executive Officer Director Maria Fardis 2 Tower Place, Floor 17 San Francisco CA CALIFORNIA 94080 Director Rajul Jain 2 Tower Place, Floor 17 San Francisco CA CALIFORNIA 94080 Director Ying Huang 2 Tower Place, Floor 17 San Francisco CA CALIFORNIA 94080 Director Derek Metzger 2 Tower Place, Floor 17 San Francisco CA CALIFORNIA 94080 Executive Officer Maha Katabi 2 Tower Place, Floor 17 San Francisco CA CALIFORNIA 94080 Director Cameron Pitt 2 Tower Place, Floor 17 San Francisco CA CALIFORNIA 94080 Executive Officer Director Biotechnology Decline to Disclose 06b true 0001891891-23-000002 2023-05-10 true true false 0 89098282 76192272 12906010 false 17 0 0 0 false Quanta Therapeutics, Inc. /s/ Perry Nisen Perry Nisen CEO 2026-06-24